Integer (NYSE:ITGR) Issues FY 2026 Earnings Guidance

Integer (NYSE:ITGR) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 6.290-6.780 for the period, compared to the consensus earnings per share estimate of 6.310. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion.

Integer Trading Up 2.2%

Integer stock opened at $84.80 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 2.45 and a current ratio of 3.32. Integer has a fifty-two week low of $62.00 and a fifty-two week high of $136.06. The stock has a market cap of $2.97 billion, a P/E ratio of 29.55, a PEG ratio of 0.76 and a beta of 0.77. The firm’s fifty day moving average price is $82.83 and its 200-day moving average price is $88.25.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.70 by $0.06. The business had revenue of $472.06 million during the quarter, compared to analysts’ expectations of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.The firm’s revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.43 earnings per share. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Equities research analysts forecast that Integer will post 6.01 earnings per share for the current fiscal year.

Integer declared that its Board of Directors has approved a stock buyback program on Tuesday, November 4th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to reacquire up to 8.3% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s management believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ITGR. Benchmark reaffirmed a “hold” rating on shares of Integer in a research note on Friday, October 24th. Weiss Ratings reissued a “sell (d+)” rating on shares of Integer in a report on Monday, December 29th. Piper Sandler dropped their price objective on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a report on Friday, October 24th. Wells Fargo & Company upped their target price on shares of Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday. Finally, Raymond James Financial restated an “outperform” rating and set a $95.00 price target (down previously from $143.00) on shares of Integer in a research report on Friday, October 24th. Four equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $101.25.

Integer News Roundup

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 results beat expectations — EPS $1.76 vs. $1.70 est and revenue $472.1M vs. $462.7M; full-year results showed 8% sales growth and strong adjusted EPS growth, supporting the company narrative of improving margins and growth execution. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Positive Sentiment: Truist raised its price target to $97 and kept a “buy” rating, signaling an analyst view of meaningful upside versus the current level. Benzinga — Truist raises target
• Neutral Sentiment: Wells Fargo also raised its target (to $84) but kept an “equal weight” rating — a modest signal that the stock is fairly valued near current levels rather than a clear endorsement. Benzinga — Wells Fargo raises target
• Neutral Sentiment: Full earnings materials (slide deck and call transcript) are available for deeper review of segment trends, backlog and margin drivers — useful for investors deciding if the beat is sustainable. Q4 Results – Earnings Call Presentation Q4 Earnings Call Transcript
• Negative Sentiment: Market reaction was mixed: some investors sold after management’s FY2026 guidance was viewed as softer than hoped, leading to an earlier pullback. Zacks notes shares fell despite the beat because guidance tempered enthusiasm. ITGR Shares Down Despite Q4 Earnings & Revenues Beat Estimates
• Negative Sentiment: Wider context: guidance midpoint and revenue outlook left some analysts noting modest downside risk versus certain targets, which could cap upside until visibility improves. MarketBeat — Earnings & Guidance Details

Hedge Funds Weigh In On Integer

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Parkside Financial Bank & Trust lifted its position in Integer by 135.5% in the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 267 shares during the last quarter. Arax Advisory Partners increased its stake in shares of Integer by 2,489.5% in the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 473 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Integer by 210.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock valued at $66,000 after buying an additional 362 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in Integer by 861.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 620 shares during the last quarter. Finally, State of Wyoming boosted its position in Integer by 434.2% during the 4th quarter. State of Wyoming now owns 1,608 shares of the medical equipment provider’s stock valued at $126,000 after buying an additional 1,307 shares during the period. 99.29% of the stock is currently owned by institutional investors.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.